Biodesix announces closing of $30M term loan
BOULDER -- Biodesix, Inc. (NASDAQ: BDSX) announced it closed on a new $30 million term loan that matures on March 1, 2026. Biodesix said it used the proceeds to repay outstanding borrowings of... Read More
Wednesday March 24, 2021
Biodesix publishes data on new COVID-19 artificial intelligence-based algorithm for use in clinical decision support systems
BOULDER -- Biodesix, Inc. (Nasdaq: BDSX) today announced a publication describing the development of a new AI-based COVID-19 algorithm and important data from a related study. The paper,... Read More
Tuesday February 9, 2021
Biodesix and HiberCell collaborate for companion diagnostic discovery, development and commercialization
BOULDER NEW YORK -- Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell , a biotechnology company developing novel therapeutics for cancer relapse and metastasis, to further... Read More
Friday January 15, 2021
Biodesix raises $72M in IPO
DENVER -- Biodesix, Inc . announced the closing of its initial public offering of 4 million shares of its common stock at a public offering price of $18 per share. The gross proceeds to... Read More
Wednesday November 4, 2020
Biodesix and Addario Lung Cancer Medical Institute initiate study to predict overall survival using checkpoint immunotherapy for lung cancer patients
BOULDER and SAN CARLOS, Calif. -- Addario Lung Cancer Medical Institute (ALCMI) and Biodesix, Inc. today announced they will begin an observational study to prospectively evaluate the clinical... Read More
Tuesday September 1, 2020
Biodesix to provide COVID-19 testing for CSU campus
BOULDER -- Biodesix, Inc. announced it will provide COVID-19 ddPCR diagnostic testing for Colorado State University as students return to campus for the fall term, which begins Aug. 24. “The... Read More
Thursday August 13, 2020
Biodesix appoints Franchi, Massarany to company's board of directors
BOULDER -- Biodesix, Inc. announced the appointment of Jean Franchi and Hany Massarany to the company’s board of directors. Ms. Franchi has more than 30 years of biotechnology and life... Read More
Wednesday July 22, 2020
Biodesix pipeline test identifies patients likely to respond to immune checkpoint inhibitors
BOULDER -- Biodesix, Inc. announced publication of research findings on a diagnostic test capable of generating valuable data to help guide the treatment of patients with advanced non-small cell... Read More
Monday July 20, 2020
IN Sponsors
Browse
Entrepreneurial by Nature
